Sparfloxacin
At a glance
- Drug Originator Dainippon Sumitomo Pharma
- Drug Licenced by AbbVie; Sam-A Corporation; Sun Pharmaceutical Industries; Teva Pharmaceutical Industries
- Drug Class Antibacterials; Fluoroquinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
- USA Patent Applicants MYLAN
- USA Patents 1
- NDAs 1
- Patent Applications 4,782
Table of Contents

Disclaimer